Dr. Chalasani is the director of the hematology-oncology division at the George Washington Cancer Center (GWCC) and co-program lead for the Clinical Translational Oncology Program. After receiving her medical degree from Gandhi Medical College in India, she completed internship, residency and a fellowship in hematology-oncology at the University of Arizona, Tucson. She joined the University of Arizona Cancer Center (UACC) as a faculty member and served as program director for the hematology-oncology fellowship program. Dr. Chalasani is the principal investigator for several clinical trials and was awarded the prestigious NCI Clinical Cancer Investigator Team Leadership Award in 2020. She has received research funding from NIH/NCI, American Cancer Society, Better Than Ever and DOD.
